投資評等
最後更新日期：2024/11/8
升級(Upgrade)
| 日期/Date | 券商
Brokerage Firm | 原評等->升級後評等
Upgrade from: -> to: | 新目標價
New Target |
| 2014/10/15 | Standpoint Research | Hold >> Buy | 144 |
| 2014/4/7 | Standpoint Research | Hold >> Buy | 118 |
| 2013/12/23 | Ladenburg Thalmann | Neutral >> Buy | 138 |
| 2013/6/20 | Standpoint Research | Hold >> Buy | |
| 2011/4/28 | Wedbush | Neutral >> Outperform | $79 >> $94 |
| 2009/5/4 | FTN Equity Capital | Neutral Buy | $70 $79 |
| 2008/11/19 | Piper Jaffray | Sell Neutral | |
降級(Downgrade)
| 日期/Date | 券商
Brokerage Firm | 原評等->降級後評等
Upgrade from: -> to: | 新目標價
New Target |
| 2015/3/4 | Standpoint Research | Buy >> Hold | |
| 2013/7/30 | Standpoint Research | Buy >> Hold | |
| 2013/5/15 | Standpoint Research | Buy >> Hold | |
| 2012/8/3 | Standpoint Research | Buy >> Hold | |
| 2011/8/25 | Maxim Group | Buy >> Hold | |
| 2011/8/25 | Auriga | Hold >> Sell | $90 >> $45 |
| 2011/6/13 | RBC Capital Mkts | Outperform >> Sector Perform | $75 >> $60 |
| 2009/8/3 | JP Morgan | Overweight >> Neutral | |
| 2009/7/31 | Wedbush Morgan | Outperform >> Neutral | $106 >> $109 |
| 2009/4/20 | Barclays Capital | Overweight Equal Weight | |
| 2005/8/8 | Rodman Renshaw | Mkt Outperform->Mkt Perform | |
| 2005/5/27 | Leerink Swann | Outperform->Mkt Perform | |
首次予以評等(Coverage Initiated)
| 日期/Date | 券商
Brokerage Firm | 原評等->升級後評等
Upgrade from: -> to: | 目標股價 |
| 2012/3/12 | Standpoint Research | Buy | 65 |
| 2011/3/25 | Deutsche Bank | Buy | 78 |
| 2011/2/23 | Stifel Nicolaus | Buy | 71 |
| 2010/4/28 | RBC Capital Mkts | Outperform | 66 |
| 2009/5/19 | Soleil | Buy | 91 |
| 2009/5/15 | Maxim Group | Buy | 96 |
| 2009/5/5 | Auriga U.S.A | Buy | 83 |
| 2009/4/6 | Lazard Capital Mkts | Buy | 98 |
| 2009/3/12 | FTN Equity Capital | Neutral | |
| 2009/3/3 | Collins Stewart | Buy | 97 |
恢復投資評等(Coverage Resumed)
| 日期/Date | 券商/Brokerage Firm | 恢復評等後等級/Resumed Rating | 目標股價Target |
| 查無資料 | | | |
重申相同投資評等(Coverage Reiterated)
| 日期/Date | 券商
Brokerage Firm | 重申相同投資評等
Reiterated Rating | 新目標價
New Target |
| 2015/7/31 | Argus | Buy | $205 >> $200 |
| 2014/8/29 | Standpoint Research | Buy | $118 >> $140 |
| 2013/12/31 | Argus | Buy | $120 >> $130 |
| 2013/3/25 | Ladenburg Thalmann | Buy | $69 >> $63 |
| 2011/2/16 | Auriga U.S.A | Buy | $72 >> $90 |
| 2011/2/16 | Wedbush | Neutral | $77 >> $79 |
| 2011/2/14 | Wedbush | Neutral | $72 >> $77 |
| 2011/1/24 | Oppenheimer | Outperform | $68 >> $77 |
| 2010/11/1 | Barclays Capital | Equal Weight | $59 >> $64 |
| 2010/10/29 | Auriga U.S.A | Buy | $70 >> $72 |